RecruitingISRCTN44366049
Ethyl eicosapentaenoate (EPA) for Depression
This study is recruiting in the United Kingdom. It is testing ethyl eicosapentaenoate (EPA) for Depression.
In United KingdomDepressionOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingISRCTN44218911
A multicentre, parallel group, study of ethyl-eicosapentaenoate (ethyl-EPA) in people with schizophrenia
This study is recruiting in the United Kingdom. It is testing ethyl-eicosapentaenoate (ethyl-EPA) for schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
RecruitingISRCTN93636537
A multidisciplinary study of the management of neuroleptic medication in schizophrenia: Educational and collaborative approaches
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomSchizophreniaOther
RecruitingISRCTN17018615
A novel targeted treatment for reducing anxiety in joint hypermobility
com can help people with Anxiety in with joint hypermobility or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomAnxietyOtherOver 18 Years
RecruitingISRCTN39055689
Parent-led intervention for anxiety
This study is recruiting in the United Kingdom. It is testing parent-led intervention for anxiety.
In United KingdomAnxietyOther
RecruitingISRCTN14644379
A patient and carer shared management intervention for anorexia
This summary needs review. Please check the official study record and contact the research team for details.
In United KingdomEating disordersOtherFrom 18 Years to 100 Years
RecruitingISRCTN67429289
A peer support programme to help adults with psychosis talk about mental health and reduce stigma
This study is looking at whether a digital support tool can help people with Schizophrenia, schizotypal and delusional disorders or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
In United KingdomSchizophreniaOtherFrom 16 Years to 100 Years
RecruitingISRCTN25163383
Study to assess the safety and PK of novel CBD soft-gel capsule
This study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOtherFrom 18 Years to 55 Years
RecruitingNCT07478744
Safety study of SYT-510 in anxiety
This study is recruiting in the United Kingdom. It is testing SYT-510 for anxiety.
In United KingdomAnxietyDrugA study involving a medication or substance.From 18 Years to 55 Years
RecruitingNCT06236880
Safety study of GM-2505 in Depression
This study is recruiting in the United Kingdom. It is testing GM-2505 for Depression.
In United KingdomDepressionDrugFrom 18 Years to 65 Years
RecruitingISRCTN33909010
Placebo- and active comparator-controlled, study to study the safety and efficacy of two doses of lurasidone HCL in acutely psychotic people with schizophrenia
This study is recruiting in the United Kingdom, in Bulgaria, in Colombia, .... It focuses on schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
RecruitingISRCTN16838597
A phase three study to study the safety and efficacy of three doses of lurasidone hydrochloride (HCl) in acutely psychotic people with schizophrenia
This study is recruiting in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
In United KingdomSchizophreniaOtherOver 18 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.